273 related articles for article (PubMed ID: 10526756)
1. Effect of exercise training on doses of oral agents and insulin.
Fujinuma H; Abe R; Yamazaki T; Seino H; Kikuchi H; Hoshino T; Hirano R; Yoshida S
Diabetes Care; 1999 Oct; 22(10):1754-5. PubMed ID: 10526756
[No Abstract] [Full Text] [Related]
2. [Insulin therapy of type 2 diabetes: from simple to flexible--three strategies are available].
Liebl A
MMW Fortschr Med; 2012 Nov; 154 Spec No 3():66-71; quiz 72-3. PubMed ID: 23724722
[No Abstract] [Full Text] [Related]
3. Non-insulin-dependent diabetes mellitus.
Flick M; Schumann L
J Am Acad Nurse Pract; 1997 Jul; 9(7):337-44; quiz 346-7. PubMed ID: 9274257
[No Abstract] [Full Text] [Related]
4. Acarbose: in search for its real indications in current medical practice.
Lerman I; Gómez Perez FJ; Aguilar-Salinas CA; Rodrigo JA
Diabetes Care; 1996 Jan; 19(1):94-5. PubMed ID: 8720547
[No Abstract] [Full Text] [Related]
5. Metformin useful in combination with exogenous insulin.
Hanuschak LN
Diabetes Care; 1996 Jun; 19(6):671-2. PubMed ID: 8725873
[No Abstract] [Full Text] [Related]
6. Initiating insulin therapy in type 2 diabetic patients failing on oral hypoglycemic agents: basal or prandial insulin? The APOLLO trial and beyond.
Bretzel RG; Eckhard M; Landgraf W; Owens DR; Linn T
Diabetes Care; 2009 Nov; 32 Suppl 2(Suppl 2):S260-5. PubMed ID: 19875561
[No Abstract] [Full Text] [Related]
7. Initiation of insulin therapy in patients with type 2 diabetes failing oral therapy: response to Mikhail and Cope and to Janka.
Raskin P
Diabetes Care; 2005 Nov; 28(11):2811. PubMed ID: 16249569
[No Abstract] [Full Text] [Related]
8. Lipoprotein(a), apolipoprotein(a) polymorphism, and insulin treatment in type II diabetic patients.
Buscaglia P; Gazzaruso C; Garzaniti A; Bonetti G; Fratino P; Geroldi D
Diabetes Care; 1995 Aug; 18(8):1202-3. PubMed ID: 7587865
[No Abstract] [Full Text] [Related]
9. Low-dose rosiglitazone in patients with type 2 diabetes mellitus requiring insulin therapy.
Lopez CA; Kanna B
Arch Intern Med; 2008 Mar; 168(5):548. PubMed ID: 18332304
[No Abstract] [Full Text] [Related]
10. [New fast-acting insulin analog. This insulin profits type l and type 2 diabetics].
Wepner U
MMW Fortschr Med; 2004 Nov; 146(47):62-3. PubMed ID: 15624662
[No Abstract] [Full Text] [Related]
11. [American Diabetes Association's Annual Meeting: new data on insulin glargine: early combination promises more success].
MMW Fortschr Med; 2005 Aug; 147(33-34):44-5. PubMed ID: 16138636
[No Abstract] [Full Text] [Related]
12. Combined insulin and sulfonylurea therapy for type 2 diabetes mellitus.
Riddle MC
Diabetes Res Clin Pract; 1991 Jan; 11(1):3-8. PubMed ID: 2019232
[No Abstract] [Full Text] [Related]
13. [Start of insulin therapy. How to ensure patient compliance?].
MMW Fortschr Med; 2006 Aug; 148(35-36):12-3. PubMed ID: 16995354
[No Abstract] [Full Text] [Related]
14. [Diabetes mellitus type 2 in the elderly. It is essential to know how to personalise the management].
Formiga F; Perez-Maraver M
Med Clin (Barc); 2014 Feb; 142(3):114-5. PubMed ID: 24378152
[No Abstract] [Full Text] [Related]
15. HbA(1c) and glycemic profile, basal- and post-treatment with Miglitol, in an area with a Mediterranean diet.
Faure E; Pallardo LF; Mesa J; Puig-Domingo M; García-Mayor R; Benito P; Ravella R; Artés M; López JS;
Diabetes Care; 2002 Oct; 25(10):1896-8. PubMed ID: 12351510
[No Abstract] [Full Text] [Related]
16. Is basal insulin always the first choice for initiation of insulin therapy in type 2 diabetic patients?
Mannucci E; Monami M; Masotti G; Marchionni N
Exp Clin Endocrinol Diabetes; 2007 May; 115(5):339-40. PubMed ID: 17516300
[No Abstract] [Full Text] [Related]
17. Insulin treatment in managing type 2 diabetes: challenges and opportunities.
Leahy J
JAAPA; 2007 Oct; Suppl Initiating Insulin():9-21. PubMed ID: 18046933
[TBL] [Abstract][Full Text] [Related]
18. [The role of insulin therapy in type 2 diabetes--current standards and recommendations].
Aulinger BA; Parhofer KG
MMW Fortschr Med; 2012 May; 154(9):49-52. PubMed ID: 22715632
[No Abstract] [Full Text] [Related]
19. Near-normoglycaemic remission in African-Americans with Type 2 diabetes mellitus is associated with recovery of beta cell function.
McFarlane SI; Chaiken RL; Hirsch S; Harrington P; Lebovitz HE; Banerji MA
Diabet Med; 2001 Jan; 18(1):10-6. PubMed ID: 11168335
[TBL] [Abstract][Full Text] [Related]
20. Clinical practice. Glycemic management of type 2 diabetes mellitus.
Ismail-Beigi F
N Engl J Med; 2012 Apr; 366(14):1319-27. PubMed ID: 22475595
[No Abstract] [Full Text] [Related]
[Next] [New Search]
